PHS
ATML

PFM Health Sciences’s ATMEL CORP ATML Stock Holding History

PFM Health Sciences’s Portfolio ATML Stock Details ATML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1,025,467
Closed -$10.1M – 112
2015
Q2 		$10.1M Buy
+1,025,467
New +$9.03M 0.26% 68

Other funds holding ATML

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RL
Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

PFM Health Sciences's ATML Position: Q3 2015 in Review

PFM Health Sciences sold out of ATMEL CORP (ATML) in Q3 2015, closing a stake of 1,025,467 shares — an estimated $10.1M sold.

PFM Health Sciences first reported a position in ATML in Q2 2015 and held it in 1 quarter. The position peaked at $10.1M in Q2 2015. 245 funds tracked by Wall St. Rank hold ATML as of Q3 2015.

  • PFM Health Sciences reported no remaining ATMEL CORP position as of Q3 2015 after selling out during the quarter.
  • PFM Health Sciences sold 1,025,467 ATMEL CORP shares in Q3 2015, an estimated $10.1M.
  • PFM Health Sciences first reported a position in ATMEL CORP in Q2 2015 and held it in 1 quarter.
  • PFM Health Sciences's ATMEL CORP position peaked at $10.1M in Q2 2015.
  • 245 funds tracked by Wall St. Rank held ATMEL CORP as of Q3 2015.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.